The Group’s expenditure related to research and development activities related to product and service development amounted to approximately EUR 4.9 (3.6) million in 2021, representing 0.2 (0.2) percent of revenue. Of the total amount EUR 2.5 (1.8) million was recognised as an expense in the income statement and EUR 2.4 (1.8) million of the development expenses was capitalised.
Investments in research and development amounted to EUR 3.1 million in 2019, representing 0.1 percent of revenue. Of the total amount EUR 1.8 million was recognised as an expense in the income statement and EUR 1.3 million of the development expenses was capitalised in 2019.